ctrl K

Price Alert

Phathom Pharmaceuticals I... (PHAT)

NASDAQ: PHAT · Real-Time Price · USD

10.26

-0.21 (-2.01%)

At close: Aug 15, 2025, 3:59 PM

10.24

-0.15%

After-hours: Aug 15, 2025, 06:01 PM EDT

Phathom Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	297.26M	381.39M	155.38M	183.26M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	505K	n/a
Other Long-Term Assets	16.09M	12.79M	299K	341K
Receivables	38.8M	1.64M	n/a	n/a
Inventory	3.21M	1.21M	n/a	n/a
Other Current Assets	20.87M	13.19M	5.13M	3.27M
Total Current Assets	360.13M	397.43M	160.51M	186.53M
Property-Plant & Equipment	2.09M	3.62M	3.49M	2.56M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	18.18M	16.41M	4.3M	2.9M
Total Assets	378.32M	413.84M	164.81M	189.43M
Account Payables	10.51M	12.6M	10M	5.15M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	708K	487K
Other Current Liabilities	74.72M	20.43M	7.74M	6.45M
Total Current Liabilities	85.73M	38.78M	26.24M	18.92M
Long-Term Debt	534.67M	137.84M	95.26M	89.67M
Other Long-Term Liabilities	546.17M	309.52M	117.03M	7.5M
Total Long-Term Liabilities	546.17M	447.82M	213.39M	98.35M
Total Liabilities	631.9M	486.6M	239.62M	117.28M
Total Debt	554.95M	139.03M	97.07M	91.34M
Common Stock	6K	5K	3K	3K
Retained Earnings	-1.26B	-928.68M	-727.09M	-529.37M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	-253.58M	-72.76M	-74.81M	72.16M
Total Investments	n/a	2.86M	505K	n/a